Crispinita D. Arroyo

Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by <i>HER2</i> Immunophenotype and Gene Amplification

Andrew D. Seidman, Monica Fornier, Francisco J. Esteva et al. · Journal of Clinical Oncology · 2001 · 550 citations

Medicine, Oncology, Pharmacology +17

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.

Paul Peter Rosen, Martin Lesser, Crispinita D. Arroyo et al. · Journal of Clinical Oncology · 1995 · 134 citations

Medicine, Oncology, Pathology +17

Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma

Bhavana Pothuri, Mario M. Leitão, Douglas A. Levine et al. · PLoS ONE · 2010 · 107 citations · Full text

Medicine, Oncology, Pathology +17

Immunohistochemical detection ofHER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis

Paul Peter Rosen, Martin Lesser, Crispinita D. Arroyo et al. · Cancer · 1995 · 104 citations · Full text

Medicine, Oncology, Pathology +10

The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity.

Rajat Bannerji, Crispinita D. Arroyo, Carlos Cordon‐Cardo et al. · The Journal of Immunology · 1994 · 84 citations · Full text

Life Sciences, Immunology, Oncology +17